Live News EQUITY FLASH L impact Nov 16, 2026, 04:44 PM UTC Novo Nordisk Says Wegovy Reduced BMI in Children With Obesity in Phase 3 Trial Novo Nordisk said Wegovy reduced BMI in children with obesity in a Phase 3 trial. NVO SquawkNews Desk